Education
About Us
Working with TipRanks
Follow Us
James Hawkins Insider Profile
4 Followers
James Hawkins, President & CEO, Director at Natus Medical, holds 97.18K shares in AudioEye (Ticker: AEYE), holds 6.38K shares in OSI Systems (Ticker: OSIS), holds 42.30K shares in Iradimed (Ticker: IRMD).
James Hawkins Natus Medical (NTUS)President & CEO, Director
Natus Medical (NTUS)
President & CEO, Director
Ranked #3,208 out of 100,956 Corporate Insiders
Profitable Transactions
26 out of 39 Profitable Transactions
Average Return
+15.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Hawkins holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 08, 2016 - Nov 08, 2017
Return:+159.20%
The most profitable trade made by James Hawkins
James Hawkins's Trading History
Natus Medical
Jan 03, 2018
―
Uninformative Buy
4.25M
$21.15M
OSI Systems
Dec 13, 2024
Director
Uninformative Sell
2.82K
$1.17M
AudioEye
Mar 05, 2025
Director
Uninformative Buy
―
$1.23M
Iradimed
Dec 10, 2024
Director
Uninformative Buy
159.67K
$2.21M
Caesars Entertainment
Jul 22, 2020
Director
Uninformative Buy
1.76M
$3.65M
Star Equity Holdings
May 08, 2014
Director
Informative Buy
33.50K
$248.60K
Iridex
Aug 22, 2014
Director
Informative Sell
4.82K
$39.43K
List of latest transactions for each holding click on a transaction to see James Hawkins's performance on stock
You May Also Like
James Hawkins insider profile FAQ
What is the percentage of profitable transactions made by James Hawkins?
The percentage of profitable transactions made by James Hawkins is 67%.
What is the average return per transaction made by James Hawkins?
The average return per transaction made by James Hawkins is 15.60%.
What stocks does James Hawkins hold?
James Hawkins holds: NTUS, OSIS, AEYE, IRMD, CZR, STRR, IRIX stocks.
What was James Hawkins’s latest transaction?
James Hawkins latest transaction was an Uninformative Buy of ―.
What was James Hawkins's most profitable transaction?
James Hawkins’s most profitable transaction was an Informative Buy of CZR stock on November 8, 2016. The return on the trade was 159.20%.
What is James Hawkins's role in Natus Medical?
James Hawkins's role in Natus Medical is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.